Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hayes William B
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Martell Robert
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MADDALUNA ANTHONY J
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pomerantz Roger
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gilbert Mark John
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Karah Hila
Indaptus Therapeutics | 8-K: Current report
Indaptus Therapeutics | 8-K: Current report
Indaptus Therapeutics | 10-Q: Quarterly report
Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Indaptus Therapeutics | DEFA14A: Others
Indaptus Therapeutics | DEF 14A: Definitive information statements
Indaptus Therapeutics | 8-K: Current report
Indaptus Therapeutics | 424B5: Prospectus
Indaptus Therapeutics | 10-K: Annual report
Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
Indaptus Therapeutics | 8-K: Current report
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Newman Michael James
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Meckler Jeffrey A
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sassi Nir
No Data